VICO — Vicore Pharma Holding AB Share News
0.000.00%
Last trade - 00:00- SEK2.73bn
- SEK1.83bn
- SEK3.82m
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2
Brief: Board Member Buys SEK 1.69 Mln Of Vicore Pharma Shares
Brief: Vicore Pharma Holding Proposes No Dividend For FY 2025
Brief: Vicore Pharma Q1 Operating Loss SEK 91.5 Mln
Brief: Vicore Pharma Q1 EBIT SEK -91.5 Million
Brief: FDA Grants Vicore's Buloxibutid Fast Track for Pulmonary Fibrosis
Brief: Vicore Pharma Q3 EBIT SEK -60.1 Million
Brief: Vicore Says Sanofi To Subscribe For Company Shares
Brief: HealthCap Subscribes For Additional Shares In Vicore's Rights Issue
Brief: Vicore Pharma Announces Rights Issue Of About SEK 782 Mln
Brief: Vicore Pharma Q2 EBIT SEK -63.1 Million
Brief: Vicore Announces Positive Final Results From Phase 2a AIR Trial
Brief: Vicore Pharma Q1 EBIT SEK 23.2 Million
Brief: Vicore Announces FDA Breakthrough Device Designation For AlmeeTM
Brief: Vicore Pharma Holding Proposes No Dividend Be Paid For 2023
Brief: Vicore Pharma Q4 EBIT SEK -120.6 Million